Account-creators
1,040
edits
Jensflorian (talk | contribs) (MAPK-altered entity added) |
Jensflorian (talk | contribs) (References added) |
||
Line 8: | Line 8: | ||
=Polymorphous low-grade tumor of the young (PLNTY)= | =Polymorphous low-grade tumor of the young (PLNTY)= | ||
* Since 2021 official WHO entity. | * Since 2021 official WHO entity.<ref name="pmid35218102">{{cite journal| author=Bale TA, Rosenblum MK| title=The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors. | journal=Brain Pathol | year= 2022 | volume= | issue= | pages= e13060 | pmid=35218102 | doi=10.1111/bpa.13060 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=35218102 }} </ref> | ||
* Abbreviated PLNTY. | * Abbreviated PLNTY. | ||
* Epilepsy-associated. | * Epilepsy-associated. | ||
Line 16: | Line 16: | ||
=Diffuse low-grade glioma, MAPK pathway-altered= | =Diffuse low-grade glioma, MAPK pathway-altered= | ||
* Since 2021 official WHO entity. | * Since 2021 official WHO entity.<ref name="pmid35218102">{{cite journal| author=Bale TA, Rosenblum MK| title=The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors. | journal=Brain Pathol | year= 2022 | volume= | issue= | pages= e13060 | pmid=35218102 | doi=10.1111/bpa.13060 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=35218102 }} </ref> | ||
* Astrocytic or oligodendroglial morphology. | * Astrocytic or oligodendroglial morphology. | ||
* Mostly in the cerebral hemispheres. | * Mostly in the cerebral hemispheres. | ||
Line 23: | Line 23: | ||
* IDH and HF3FA mutations and CDKN2A deletions not compatible with this diagnosis. | * IDH and HF3FA mutations and CDKN2A deletions not compatible with this diagnosis. | ||
* Mutations in BRAF (V600E), FGFR1 or duplication in FGFR1 TKD. | * Mutations in BRAF (V600E), FGFR1 or duplication in FGFR1 TKD. | ||
=References= |